NFKB1 and hepatocellular carcinoma: COMMD10, unlike COMMD7, inhibits HCC cell proliferation by inhibits the NF-κB signaling pathway and enhances cell death by activating the signaling pathway of Bcl‐2/Bax/caspase-9/3.